Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Ed Kanfer(Fred Hutch Cancer Center), Howard M. Shulman(Fred Hutch Cancer Center), D. B. Amos(Florida College), R Clift, CD Buckner(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), A Fefer(University of Washington), R Storb(Fred Hutch Cancer Center), K Doney(University of Washington Medical Center), F R Appelbaum(City Of Hope National Medical Center), R.S. Hill(Fred Hutch Cancer Center)
PubMed
April 1, 1987
Cited by 23
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors
|Hepatology|1984|852
Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or Lymphoma
|New England Journal of Medicine|1989|687